Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 50 of 58, showing 10 Applications out of 576 total, starting on record 491, ending on 500

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

491.

ECCT/14/12/01   Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE)
    XALIA LEA- Xarelto® for Long-term and  Initial Anticoagulation in Venous  Thromboembolism (VTE) in Latin America,  EMEA and Asia   
Principal Investigator(s)
1. Anne Njeri Mugera Njambi Mugera
2. Dr. Martin N Wanyoike Njoroge Wanyoike
3. Charles Muthui Kariuki Muthui Kariuki
4. FEROZ ALI Allibhoy
Site(s) in Kenya
1. Primecare Heart Clinic (Nairobi City county)
2. Dr. Silversteins Clinic (Nairobi City county)
3. Nairobi Cardiovascular Clinic (Nairobi City county)
4. Agah Khan Kisumu (Kisumu county)
 
27-01-2015 View

492.

ECCT/14/11/01   ZEBOV Trial
      A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Volunteers in Kilifi, Kenya.                
Principal Investigator(s)
1. Philip Bejon
2. Patricia Njuguna
Site(s) in Kenya
KEMRI Wellcome Trust Research Programme
 
08-12-2014 View

493.

ECCT/15/01/05   In vivo efficacies of AL and DP
    Open label randomized study evaluating the in vivo efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in children under five years of age in western Kenya.   
Principal Investigator(s)
1. AAron Samuels
2. Simon Kariuki
Site(s) in Kenya
Siaya District Hospital
 
03-03-2015 View

494.

ECCT/14/09/04  
    Assessment of Safety and Efficacy of Brozedex Syrup in the Treatment of Productive Cough. Phase III, Randomized, Double Blind, Placebo-Controlled, Parallel Group and Multi-Site Study Conducted In Nairobi in three sites    
Principal Investigator(s)
1. Hudson Aubrey Lodenyo
Site(s) in Kenya
1. Rhodes Clinic/Ngaira Health Centre (Nairobi City county)
2. Mbagathi District Hospital (Nairobi City county)
3. Mama Lucy Hospital (Nairobi City county)
 
09-12-2014 View

495.

ECCT/14/10/02  
    Acronymn: CRASH-3   Short Title: Clinical Randomisation of an Antifibrinolytic in Significant Head Injury   Full Title: Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial   ISRCTN15088122   ClinicalTrials.gov ID: NCT01402882    
Principal Investigator(s)
1. Kiboi Githinji Julius
2. Dullo Michael
3. Lallet Tasneem Essaji
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Kitui District Hospital (Kitui county)
3. The Nairobi Hospital (Nairobi City county)
 
05-02-2015 View

496.

ECCT/15/02/05  
    An open-label clinical trial to assess the pharmacokinetics and safety of miltefosine allometric dose for the treatment of children with primary visceral leishmaniasis in Eastern Africa   
Principal Investigator(s)
1. Rashid Juma
Site(s) in Kenya
1. Kimalel Health Centre (Baringo county)
2. Kacheliba District Hospital (West Pokot county)
 
09-04-2015 View

497.

ECCT/14/09/03   Breast Feeding Study
    An open-label, short-duration, repeat-dose study of breast milk excretion and infant absorption of daily oral Tenofovir Disoproxil Fumarate/Emtricitabine when used by HIV-1 uninfected lactating women    
Principal Investigator(s)
1. Jared Murray Baeten
2. Nelly Rwamba Mugo
Site(s) in Kenya
Partners in Prevention, Thika Site
 
19-08-2015 View

498.

ECCT/14/09/02   LIVING STUDY-PHASE III B.
    Prospective study of Lopinavir based ART for HIVInfected childreNGlobally (LIVING study)   
Principal Investigator(s)
1. Elizabeth Maleche Obimbo
2. Elizabeth Bukusi
3. Winstone Nyandiko
4. Bienvenu Baruani Ngoy
5. Joseph Kariuki Mbuthia
6. Allan Godfrey Otieno
7. Lucy Koech
8. Neema Mturi
9. Beatrice Mutai
Site(s) in Kenya
1. University of Nairobi/ Kenyatta National Hospital (Nairobi City county)
2. AMPATH, Moi University Teaching and Referral Hospital Eldoret (Uasin Gishu county)
3. MSF Belgium Kibera Clinic (Nairobi City county)
4. Gertrude\'s Children\'s Hospital (Nairobi City county)
5. Mbagathi District Hospital (Nairobi City county)
 
08-12-2014 View

499.

ECCT/14/09/01   Extension to study MALARIA-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa
    An open extension to the phase III, multi-center study MALARIA-055 PRI (110021) to evaluate long-term efficacy, safety and immunogenicity of the RTS,S/AS01E candidate vaccine against malaria disease caused by Plasmodium falciparum in infants and children in Africa.   Study number: MALARIA-076 (200599)   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project
 
23-09-2015 View

500.

ECCT/14/08/02   A5288
    Management Using the Latest Technologies in Resource-limited Settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)   
Principal Investigator(s)
1. ESTHER MUMBI MAKANGA
Site(s) in Kenya
KEMRI/CDC CLINICAL RESEARCH CENTRE
 
08-09-2014 View